AGP Picks
View all

Your daily news update on Africa

Provided by AGP

Got News to Share?

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on April 29, 2026

MegaWatt Announces Settlement of Debt by Issuance of Shares
United States Lime & Minerals Reports First Quarter 2026 Results and Declares Regular Quarterly Cash Dividend
OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026
Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
Parexel Adds New Technology Capabilities in Patient Safety Solutions with Acquisition of Vitrana
Sapho Bio Secures $5M, Advances Rapid Sterility Testing Through USP<1223> Validation
Mobility Infotech Launches New Multi-City Fleet Management Feature for Uber Clone App in the UAE
YWO Launches New Digital Affiliate Program with Three Structured Payout Models
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
Codexis to share RNA manufacturing advances at TIDES USA
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
Century Aluminum Sets Date for First Quarter 2026 Earnings Announcement
RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET
ALPHAMIN ANNOUNCES CAD$0.13 PER SHARE FINAL FY2025 DIVIDEND/ FILES Q1 2026 FINANCIAL STATEMENTS AND MD&A
Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias

Share us

on your social networks:

Sign up for:

Modern Africa Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.